The serotonin 2C receptor (5‐HT2CR) is the primary receptor through which 5‐HT impacts feeding and body weight and 5‐HT2CR agonist lorcaserin was released for obesity treatment in 2012. The gene discussed is HTR2C; the disease is Obesity.